Sign Up to like & get
recommendations!
0
Published in 2019 at "Leukemia research"
DOI: 10.1016/j.leukres.2019.106166
Abstract: About ˜80% of mast cell neoplasm patients harbor the c-Kit activating mutation D816 V, which is associated with c-Kit inhibitor resistance and poor prognosis. However, the molecular basis for these effects is not fully known. To…
read more here.
Keywords:
pim;
d816;
pim kinases;
neoplastic mast ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0175514
Abstract: Gain-of-function mutations in Kit receptor tyrosine kinase result in the development of a variety of cancers, such as mast cell tumours, gastrointestinal stromal tumours (GISTs), acute myeloid leukemia, and melanomas. The drug imatinib, a selective…
read more here.
Keywords:
akt;
pathway neoplastic;
mast cells;
kit ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14133070
Abstract: Simple Summary Advanced systemic mastocytosis (AdvSM) is a rare malignant disease with a poor prognosis due to the drug resistance of neoplastic mast cells. We found that drugs targeting the cell cycle regulators CDK4 and…
read more here.
Keywords:
growth;
cdk6 inhibitors;
mast cells;
cdk4 cdk6 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of the American Animal Hospital Association"
DOI: 10.5326/jaaha-ms-7150
Abstract: Luteinizing hormone receptors (LHRs) are expressed in canine lymphoma and hemangiosarcoma. We hypothesized that LHR would be expressed in canine mast cell tumors (MCTs) and that more neoplastic mast cells would express LHR in gonadectomized…
read more here.
Keywords:
gonadectomized dogs;
mast;
expression;
mast cells ... See more keywords